IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2622
Positioning
Market Dominance
Services
Healthcare
$273M
Oguzhan Atay
BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. At the heart of this technological breakthrough lies our patented QCTs, enabling measurements at the physical limit of detection – the single DNA molecule. Our principal executive offices are located in Menlo Park, CA.
Headcount
620
HQ Base
NEWARK, California
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = BLLN ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$BLLN BillionToOne, Inc. | 46 | 69 | 67 | 27 | 515.0x | 231.7x | - | 7.0% | 69.9% | 11.5% | 6.8% | 117.4% | 0.0% | - | $273M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
BillionToOne, Inc. (BLLN) receives a "Reduce" rating with a composite score of 46.1/100. It ranks #2622 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Asset base utilization
Direct cash return
Oguzhan Atay
Chief Executive Officer
Labor Force
620
69
25
37
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for BLLN
Lagging peers — losers tend to keep underperforming
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for BLLN.
View All RatingsInsufficient data for Financial Analysis
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 69 | 85 | -16DRAG |
| MOMENTUM | 27 | 20 | +7ALPHA |
| VALUATION | 67 | 75 | -8DRAG |
| INVESTMENT | 25 | 16 | +9ALPHA |
| STABILITY | 37 | 31 | +6ALPHA |
| SHORT INT | 30 | 17 | +13ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
Insufficient data for ROIC calculation
GM 70% vs sector 60%, OM 12% vs sector 4%
Capital turnover N/A, R&D intensity 15.5%
Rev growth 117%
Interest coverage 481.6x, Net debt/EBITDA -34.4x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
BillionToOne, Inc. receives a Reduce rating from our analysis, with a composite score of 46.1/100 and 2 out of 5 stars, ranking #2622 out of 7,333 stocks. BLLN's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
BLLN earns a quality score of 69/100, indicating above-average business quality. The company reports gross margins of 69.9% (sector avg: 59.6%), net margins of 6.8% (sector avg: 2.3%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
BLLN's value score of 67/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 515.00x, an EV/EBITDA of 231.73x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
BillionToOne, Inc.'s investment score of 25/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 117.4% vs. a sector average of 7.8% and a return on assets of 7.0% (sector: 1.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
BillionToOne, Inc. is experiencing notably weak momentum with a score of just 27/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 117.4% year-over-year, while a beta of 2.23 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
BLLN's stability score of 37/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 2.23. Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
BillionToOne, Inc.'s short interest score of 30/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include high market sensitivity (beta: 2.23), micro-cap liquidity risk. At $273M (micro-cap), BLLN carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
BillionToOne, Inc. is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #2622 of 7,333 overall (64th percentile). Key comparisons include operating margins of 11.5% above the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While BLLN currently exhibits a REDUCE profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Investment (25) would have the largest impact on the composite score.
EV/EBITDA 1876% ABOVE SECTOR MEDIAN
Gross Margin 17% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 228% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate BillionToOne, Inc. (BLLN) as a Reduce with a composite score of 46.1/100 at a current price of $70.58. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential and elevated risk of underperformance relative to peers over the next 12 months.
The rating is primarily driven by strength in quality (69th percentile) and value (67th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (25th percentile) and momentum (27th percentile) tempers our overall conviction. We assign a Narrow Moat rating (54/100), High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; sustainability of the current growth rate. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
BillionToOne, Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 46.1/100 places it at rank #2622 in our full 7,333-stock universe. At $273M in market capitalization, BillionToOne, Inc. is a small-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 117%, though momentum at the 27th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 70% (+10.4pp vs sector) narrow to operating margins of 12% (+8.0pp vs sector) and net margins of 6.8%, yielding a gross-to-net conversion rate of 10%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $70.58, BillionToOne, Inc. is trading near fair value based on current fundamentals. Our value factor score of 67/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 515.0x (a 2069% premium to the sector median of 23.7x), EV/EBITDA of 231.7x (at a premium), P/S of 11.7x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis partially supports given strong quality metrics.
Gross margins of 70% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 117% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A value factor score of 67/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
The Reduce rating (composite 46.1/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
A P/E of 515.0x leaves little room for execution misses — any earnings disappointment could trigger a sharp multiple compression.
We assign a High uncertainty rating to BillionToOne, Inc.. Key risk factors include elevated market sensitivity (beta of 2.23), below-average price stability (37th percentile), elevated valuation multiple (P/E 515.0x) that leaves limited margin for error. The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 2.23); below-average price stability (37th percentile); elevated valuation multiple (P/E 515.0x) that leaves limited margin for error. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 37th percentile and quality factor at the 69th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 70% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate BillionToOne, Inc.'s capital allocation as Poor. Key concerns include suboptimal returns on capital. Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — BillionToOne, Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, BillionToOne, Inc. receives a Reduce rating with a composite score of 46.1/100 (rank #2622 of 7,333). Our quantitative framework assigns a Narrow Moat (54/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 45/100.
Our analysis does not support a constructive view on BillionToOne, Inc. at this time. The combination of the current quantitative profile, high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign BillionToOne, Inc. a Narrow Moat rating with a composite moat score of 54/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that BillionToOne, Inc. can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being financial resilience at 17.5/20.
The strongest moat sources are financial resilience (17.5/20) and margin superiority (13.2/20). Interest coverage 481.6x, Net debt/EBITDA -34.4x. GM 70% vs sector 60%, OM 12% vs sector 4%. These pillars form the core of BillionToOne, Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (5/20) and reinvestment efficiency (5.4/20). Insufficient data for ROIC calculation. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect BillionToOne, Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 70% providing a solid profitability foundation, operating margins of 12% reflecting effective cost management, robust top-line growth of 117% expanding the revenue base. The margin cascade from 70% gross to 12% operating to 6.8% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 69th percentile.
The margin profile shows gross margins of 70%, operating margins of 12%, net margins of 6.8%. Return metrics include ROA of 7.0%. Relative to the Services sector, gross margins are 10.4 percentage points above the sector median of 60%.
The balance sheet reflects revenue growth of 117%. Overall balance sheet health is adequate for the current business environment.
Weak momentum (27th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
High beta of 2.23 means amplified losses in market selloffs — in a broad market correction, this stock would likely decline more than the index.
MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, March 4, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:
As major stock indexes in the United States have recently experienced significant gains, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs, investors are keenly observing opportunities for value investments. In this context, identifying undervalued stocks that may offer potential growth is crucial, as these picks can provide a strategic advantage amidst fluctuating market conditions.

BillionToOne, a molecular diagnostics company, successfully completed its initial public offering (IPO) on the Nasdaq Global Select Market, raising approximately $314.0 million by selling 5,233,765 shares of Class A common stock at $60.00 per share.
As the U.S. stock market kicked off February with a strong performance, highlighted by significant gains in major indices like the Dow Jones and S&P 500, investors are keenly observing growth companies that insiders are heavily investing in. In this thriving market environment, companies with high insider ownership often signal confidence from those who know the business best, making them an intriguing focus for those looking to understand where growth potential may lie.
This diagnostics firm delivers precision molecular testing for prenatal and oncology use to hospitals and research centers.
Above 50MA
37.18%
Net New Highs
+51081